Article
Alterations of DNA damage response genes correlate with response and overall survival in anti-PD-1/PD-L1-treated advanced urothelial cancer.
Cancer medicine - 1 Dec 2020
Joshi Monika, Grivas Petros, Mortazavi Amir, Monk Paul, Clinton Steven K, Sue-Ann Woo Michele, Holder Sheldon L, Drabick Joseph J, Yin Ming
Abstract excerpt
DNA damage response (DDR) gene alterations in cancer are associated with a higher tumor mutational burden (TMB) and may impact clinical outcomes of urothelial cancer (UC). Here, we explore the prognostic role of DDR alterations in advanced UC treated with anti-PD-1/PD-L1 agents. The study included 53 patients who had FoundationOne genomic sequencing and received anti-PD-1/PD-L1 therapy. Fisher exact test and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
